CORE LABS INC (CLB)
(Delayed Data from NYSE)
$19.82 USD
+0.12 (0.61%)
Updated Jan 23, 2025 04:00 PM ET
After-Market: $19.85 +0.03 (0.15%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for Core Laboratories Inc falls in the month of December .
All items in Millions except EPS data.
12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | |
---|---|---|---|---|---|
Sales | NA | 510 | 490 | 470 | 487 |
Cost Of Goods | NA | 400 | 394 | 368 | 375 |
Gross Profit | NA | 110 | 96 | 102 | 113 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 55 | 55 | 57 | 189 |
Income After Depreciation & Amortization | 0 | 55 | 42 | 45 | -77 |
Non-Operating Income | NA | 0 | 0 | 0 | 0 |
Interest Expense | NA | 13 | 12 | 9 | 14 |
Pretax Income | NA | 41 | 30 | 36 | -91 |
Income Taxes | NA | 4 | 10 | 16 | 6 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 37 | 20 | 20 | -97 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 37 | 19 | 20 | -98 |
Depreciation Footnote | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 70 | 59 | 64 | -56 |
Depreciation & Amortization (Cash Flow) | NA | 16 | 17 | 19 | 21 |
Income After Depreciation & Amortization | 0 | 55 | 42 | 45 | -77 |
Earnings Per Share Data | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 47.52 | 46.81 | 46.69 | 44.48 |
Diluted EPS Before Non-Recurring Items | NA | 0.71 | 0.57 | 0.71 | 0.80 |
Diluted Net EPS (GAAP) | NA | 0.78 | 0.42 | 0.42 | -2.20 |
Fiscal Year end for Core Laboratories Inc falls in the month of December .
All items in Millions except EPS data.
12/31/24 | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | |
---|---|---|---|---|---|
Sales | NA | 134.40 | 130.58 | 129.64 | 128.21 |
Cost Of Goods | NA | 106.81 | 102.93 | 104.59 | 101.52 |
Gross Profit | NA | 27.59 | 27.65 | 25.05 | 26.69 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 7.79 | 11.64 | 16.48 | 12.11 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 19.80 | 16.01 | 8.57 | 14.58 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 3.11 | 3.21 | 3.42 | 3.62 |
Pretax Income | NA | 16.70 | 12.80 | 5.15 | 10.96 |
Income Taxes | NA | 4.69 | 3.61 | 1.66 | 8.53 |
Minority Interest | NA | 0.26 | 0.16 | 0.27 | 0.24 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 12.00 | 9.19 | 3.49 | 2.43 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 11.75 | 9.03 | 3.22 | 2.20 |
Earnings Per Share Data | 12/31/24 | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 47.82 | 47.74 | 47.70 | 47.56 |
Diluted EPS Before Non-Recurring Items | NA | 0.27 | 0.22 | 0.13 | 0.19 |
Diluted Net EPS (GAAP) | NA | 0.25 | 0.19 | 0.07 | 0.06 |